We are live on ! Find out more
CPX

Canaan Partners XI Portfolio holdings

AUM $127M
1-Year Est. Return 217.49%
This Fund
S&P 500
This Quarter Est. Return
-7.1%
1 Year Est. Return
+217.49%
3 Year Est. Return
+1,311.52%
5 Year Est. Return
10 Year Est. Return
AUM
$82.6M
AUM Growth
-$8.07M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
3
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 88.72%
2 Technology 11.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TYRA icon
1
Tyra Biosciences
TYRA
$1.91B
$70.5M 85.38%
4,409,991
AEVA
2
Aeva Technologies
AEVA
$1.26B
$9.32M 11.28%
3,697,039
RLYB icon
3
Rallybio
RLYB
$84.6M
$2.76M 3.34%
257,464

Similar funds

Canaan Partners XI's Q2 2024 Portfolio in Review

As of Q2 2024, Canaan Partners XI held 3 positions worth $82.6M, down 8.9% from $90.7M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2024: portfolio turnover was 0%. Canaan Partners XI opened no new positions and made no exits, leaving the 3-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 89% of assets, up from 84% a quarter earlier, followed by Technology.

  • Canaan Partners XI's ten largest holdings make up 100% of its $82.6M portfolio in Q2 2024.
  • Canaan Partners XI opened 0 new positions and closed 0 in Q2 2024.
  • Canaan Partners XI's portfolio value fell 8.9% quarter-over-quarter to $82.6M.

Based on Canaan Partners XI's 13F filing for Q2 2024, filed 9 Jul 2024.